All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Thousand Colony Forming Units | NCIT_C68895 | [A unit of viable cell quantity equal to 10E3 colony forming units (10E3 CFU).] |
| Government Funding Serial Number | NCIT_C93840 | [A character string that represents the six-digit number generally assigned sequentially to a funding mechanism within an institute, center, or division.] |
| Serial Number | NCIT_C73518 | [A unique identifier assigned to a member of a series of similar items.] |
| Million Colony Forming Units | NCIT_C68896 | [A unit of measurement of viable cell quantity equal to 10E6 colony forming units (10E6 CFU).] |
| Government Funding Type Code | NCIT_C93841 | [A coded value specifying the kind of application received and processed.] |
| Transcription Factor 21 | NCIT_C54234 | [Transcription factor 21 (179 aa, ~20 kDa) is encoded by the human TCF21 gene. This trancription factor is involved in epithelial-mesenchymal interactions, epicardial differentiation and kidney and lung morphogenesis.] |
| TCF21 Gene | NCIT_C54232 | [This gene plays a role in embryonic trancriptional regulation.] |
| Health Care Provider Effective Date Range | NCIT_C93842 | [The date and time span for when the healthcare provider is active.] |
| Malignant Large Squamous Cell | NCIT_C54235 | |
| Health Care Provider Identifier | NCIT_C93843 | [A unique symbol that establishes identity of the healthcare provider.] |
| Malignant Acantholytic Squamous Cell | NCIT_C54236 | |
| Health Care Provider Postal Address | NCIT_C93844 | [A contact point used to send physical forms of communication to the healthcare provider.] |
| NFE2L2 Gene | NCIT_C54237 | [This gene plays a role in transcriptional regulation.] |
| Healthcare Facility Effective Date Range | NCIT_C93845 | [The date and time span for when the healthcare facility is active.] |
| NFE2L2 wt Allele | NCIT_C54238 | [Human NFE2L2 wild-type allele is located in the vicinity of 2q31 and is approximately 162 kb in length. This allele, which encodes nuclear factor erythroid 2-related factor 2 protein, is involved in the mediation of transcription by RNA polymerase II.] |
| Healthcare Facility Identifier | NCIT_C93846 | [A unique symbol that establishes identity of the healthcare facility.] |
| 2q31 | NCIT_C54239 | [A chromosome band present on 2q] |
| Healthcare Facility Postal Address | NCIT_C93847 | [A contact point used to send physical forms of communication to the healthcare facility.] |
| Healthcare Provider Group Effective Date Range | NCIT_C93848 | [The date and time span for when the healthcare provider group is active.] |
| Nadolol | NCIT_C29280 | [A non-selective beta-adrenergic antagonist with antihypertensive and antiarrhythmic activities. Nadolol competitively blocks beta-1 adrenergic receptors located in the heart and vascular smooth muscle, inhibiting the activities of the catecholamines epinephrine and norepinephrine and producing negative inotropic and chronotropic effects. This agent exhibits antiarrhythmic activity via the impairment of atrioventricular (AV) node conduction and a corresponding reduction in sinus rate. In the kidney, inhibition of the beta-2 receptor within the juxtaglomerular apparatus results in the inhibition of renin production and a subsequent reduction in angiotensin II and aldosterone levels, thus inhibiting angiotensin II-dependent vasoconstriction and aldosterone-dependent water retention.] |